ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,250.80
1.27%
Dow Jones
40,421.36
0.33%
Brent Oil
81.515
-0.93%
Bitcoin
67,572.73
-0.86%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Codexis Inc (CDXS)

  7. Codexis Inc (CDXS) News

CDXS

Codexis (CDXS)

Codexis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CDXS
DateTimeSourceHeadlineSymbolCompany
07/18/20244:05PMGlobeNewswire Inc.Codexis to Report Second Quarter 2024 Financial Results on August 8NASDAQ:CDXSCodexis Inc
07/12/20244:15PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CDXSCodexis Inc
07/01/20244:05PMGlobeNewswire Inc.Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy AssetsNASDAQ:CDXSCodexis Inc
06/13/20246:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
06/13/20246:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
06/13/20246:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
06/13/20246:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
06/13/20246:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
06/13/20246:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
06/13/20246:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
06/13/20244:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
05/22/20244:25PMGlobeNewswire Inc.Codexis to Participate in Jefferies Global Healthcare ConferenceNASDAQ:CDXSCodexis Inc
05/20/20244:05PMGlobeNewswire Inc.Codexis to Participate in TD Cowen 2nd Annual Sustainability WeekNASDAQ:CDXSCodexis Inc
05/14/20249:11AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CDXSCodexis Inc
05/14/20246:52AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
05/14/20246:00AMGlobeNewswire Inc.Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual MeetingNASDAQ:CDXSCodexis Inc
05/02/20244:05PMGlobeNewswire Inc.Codexis Reports First Quarter 2024 Financial ResultsNASDAQ:CDXSCodexis Inc
04/18/20244:05PMGlobeNewswire Inc.Codexis to Report First Quarter 2024 Financial Results on May 2NASDAQ:CDXSCodexis Inc
04/11/20247:05AMGlobeNewswire Inc.Codexis Appoints Carole Cobb, MBA, to Strategic Advisory BoardNASDAQ:CDXSCodexis Inc
03/06/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
02/28/20244:05PMGlobeNewswire Inc.Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:CDXSCodexis Inc
02/27/202412:15PMAllPennyStocks.comBiotech Rallied Strongly On Exclusive Licensing AgreementNASDAQ:CDXSCodexis Inc
02/26/20244:05PMGlobeNewswire Inc.Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with RocheNASDAQ:CDXSCodexis Inc
02/26/20248:05AMGlobeNewswire Inc.Codexis to Participate in TD Cowen 44th Annual Health Care ConferenceNASDAQ:CDXSCodexis Inc
02/20/20248:05AMGlobeNewswire Inc.Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory BoardNASDAQ:CDXSCodexis Inc
02/16/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
02/14/20244:51PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CDXSCodexis Inc
02/14/20244:05PMGlobeNewswire Inc.Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28NASDAQ:CDXSCodexis Inc
02/13/20244:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
02/13/20244:05PMGlobeNewswire Inc.Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key MilestonesNASDAQ:CDXSCodexis Inc
 Showing the most relevant articles for your search:NASDAQ:CDXS

Your Recent History

USOTC
ITUP
Interups (CE)
USOTC
IDVV
International Endeavors (PK)
NYSE
AMC
AMC Entertainment
USOTC
MGON
Megola (PK)
USOTC
GRLT
Grillit (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
CNNA
Cann American (CE)
USOTC
HIRU
Hiru (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
NBRI
North Bay Resources (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
CRTG
Coretec (QB)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
LWLG
Lightwave Logic
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved